HEADER ANTIMICROBIAL PROTEIN 29-MAR-14 2MN8 TITLE NMR STRUCTURE OF A PEPTOID ANALOGUE OF MACULATIN G15 CONTAINING CIS- TITLE 2 NLEU AT POSITION 13 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACULATIN G15; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MACULATIN-1.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: LITORIA GENIMACULATA; SOURCE 4 ORGANISM_COMMON: GREEN-EYED TREE FROG; SOURCE 5 ORGANISM_TAXID: 95132; SOURCE 6 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS PEPTOID, N-SUBSTITUTED GLYCINE, MACULATIN, ANTIMICROBIAL PEPTIDE, KEYWDS 2 ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.E.UGGERHOEJ,P.GUENTERT,R.WIMMER REVDAT 2 03-DEC-14 2MN8 1 JRNL REVDAT 1 23-JUL-14 2MN8 0 JRNL AUTH L.E.UGGERHJ,J.K.MUNK,P.R.HANSEN,P.GUNTERT,R.WIMMER JRNL TITL STRUCTURAL FEATURES OF PEPTOID-PEPTIDE HYBRIDS IN JRNL TITL 2 LIPID-WATER INTERFACES. JRNL REF FEBS LETT. V. 588 3291 2014 JRNL REFN ISSN 0014-5793 JRNL PMID 25063337 JRNL DOI 10.1016/J.FEBSLET.2014.07.016 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MN8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-APR-14. REMARK 100 THE RCSB ID CODE IS RCSB103817. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 310.1 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 3 MM ENTITY_1-1, 2 MM SODIUM REMARK 210 AZIDE-2, 150 MM [U-2H] SDS-3, 10 REMARK 210 MM POTASSIUM PHOSPHATE-4, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H NOESY; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 1.3, CARA 1.8.4, CYANA REMARK 210 2.1, TALOS+ REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 I4G A 13 -154.52 79.67 REMARK 500 2 I4G A 13 -159.76 70.91 REMARK 500 2 ALA A 16 -70.91 -51.68 REMARK 500 3 I4G A 13 140.71 136.11 REMARK 500 4 ALA A 16 -71.11 -51.75 REMARK 500 5 ALA A 16 -71.19 -51.69 REMARK 500 7 HIS A 12 63.99 -153.77 REMARK 500 7 I4G A 13 -157.08 74.05 REMARK 500 7 ALA A 16 -70.86 -51.72 REMARK 500 8 ALA A 16 -71.08 -51.72 REMARK 500 10 HIS A 12 57.02 -152.77 REMARK 500 10 I4G A 13 -164.05 58.13 REMARK 500 10 VAL A 14 25.86 -141.93 REMARK 500 10 ALA A 16 -71.12 -51.72 REMARK 500 12 I4G A 13 139.94 136.59 REMARK 500 13 I4G A 13 -150.11 72.09 REMARK 500 13 ALA A 16 -70.92 -51.74 REMARK 500 14 I4G A 13 164.33 66.72 REMARK 500 15 HIS A 12 57.02 -152.84 REMARK 500 15 I4G A 13 -168.69 58.18 REMARK 500 17 I4G A 13 -158.00 90.53 REMARK 500 18 I4G A 13 -150.64 72.83 REMARK 500 18 VAL A 14 25.11 -142.17 REMARK 500 19 VAL A 14 25.58 -144.45 REMARK 500 20 I4G A 13 -161.20 -117.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2MMJ RELATED DB: PDB REMARK 900 PEPTOID ANALOGUE OF MACULATIN G15 (TRANS-NLEU AT POSITION REMARK 900 11) REMARK 900 RELATED ID: 19856 RELATED DB: BMRB REMARK 900 PEPTOID ANALOGUE OF MACULATIN G15 (TRANS-NLEU AT POSITION REMARK 900 11) REMARK 900 RELATED ID: 19882 RELATED DB: BMRB REMARK 900 RELATED ID: 2MN9 RELATED DB: PDB DBREF 2MN8 A 1 22 PDB 2MN8 2MN8 1 22 SEQRES 1 A 22 GLY LEU PHE GLY VAL LEU ALA LYS VAL ALA ALA HIS I4G SEQRES 2 A 22 VAL GLY ALA ILE ALA GLU HIS PHE NH2 MODRES 2MN8 I4G A 13 GLY N-(2-METHYLPROPYL)GLYCINE HET I4G A 13 19 HET NH2 A 22 3 HETNAM I4G N-(2-METHYLPROPYL)GLYCINE HETNAM NH2 AMINO GROUP FORMUL 1 I4G C6 H13 N O2 FORMUL 1 NH2 H2 N HELIX 1 1 LEU A 2 HIS A 12 1 11 HELIX 2 2 VAL A 14 PHE A 21 1 8 LINK C HIS A 12 N I4G A 13 1555 1555 1.54 LINK C I4G A 13 N VAL A 14 1555 1555 1.33 LINK C PHE A 21 N NH2 A 22 1555 1555 1.52 CISPEP 1 HIS A 12 I4G A 13 1 5.90 CISPEP 2 HIS A 12 I4G A 13 2 5.96 CISPEP 3 HIS A 12 I4G A 13 3 6.02 CISPEP 4 HIS A 12 I4G A 13 4 6.04 CISPEP 5 HIS A 12 I4G A 13 5 5.94 CISPEP 6 HIS A 12 I4G A 13 6 5.96 CISPEP 7 HIS A 12 I4G A 13 7 6.02 CISPEP 8 HIS A 12 I4G A 13 8 5.88 CISPEP 9 HIS A 12 I4G A 13 9 6.02 CISPEP 10 HIS A 12 I4G A 13 10 5.98 CISPEP 11 HIS A 12 I4G A 13 11 6.00 CISPEP 12 HIS A 12 I4G A 13 12 5.93 CISPEP 13 HIS A 12 I4G A 13 13 5.92 CISPEP 14 HIS A 12 I4G A 13 14 6.00 CISPEP 15 HIS A 12 I4G A 13 15 5.97 CISPEP 16 HIS A 12 I4G A 13 16 6.02 CISPEP 17 HIS A 12 I4G A 13 17 5.98 CISPEP 18 HIS A 12 I4G A 13 18 5.95 CISPEP 19 HIS A 12 I4G A 13 19 5.93 CISPEP 20 HIS A 12 I4G A 13 20 6.00 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 121 0 2 2 0 0 0 6 0 0 0 2 END